SEARCH Articles Figures Tables Arthritis, treatment monoclonal antibody therapy Bivalent and Bispecific Monoclonal Antibodies in Cancer Therapy Breast cancer monoclonal antibody therapy CD20, monoclonal antibody therapy target Cancer, treatment monoclonal antibody therapy General Aspects of Monoclonal Antibody Therapy Hepatitis monoclonal antibody therapy Monoclonal antibodies in cancer therapy Monoclonal antibody cancer therapies Monoclonal antibody therapy CD20 targeting Monoclonal antibody therapy Ibritumomab Tiuxetan Monoclonal antibody therapy Tositumomab Monoclonal antibody therapy bispecific antibodies Monoclonal antibody therapy considerations Monoclonal antibody therapy idiotype Monoclonal antibody therapy immunotoxins Monoclonal antibody therapy in rheumatoid arthritis Monoclonal antibody therapy interleukin-1 targeting Monoclonal antibody therapy overview Monoclonal antibody therapy radioimmunotherapy Monoclonal antibody therapy resistance Monoclonal antibody therapy rheumatoid arthritis Monoclonal antibody therapy rituximab Monoclonal antibody therapy trastuzumab Mouse monoclonal antibody therapies Organ transplants, monoclonal antibody therapy Rheumatoid arthritis, treatment monoclonal antibody therapy Targeted therapy, monoclonal antibodies used Trastuzumab, cancer monoclonal antibody therapy Tumor necrosis factor, monoclonal antibody therapy